Related Experiment Video

Updated: Jun 27, 2026

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

[Influenza vaccination coverage in asthmatic children in France in 2006-2007]

F Rancé1, C Chave, J de Blic

  • 1Service de pédiatrie-pneumologie-allergologie hôpital-des-enfants, CHU de Toulouse, 330 avenue de Grande-Bretagne, 31059 Toulouse cedex 9, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|December 18, 2008
PubMed

Insights

Annual influenza vaccination for children with asthma in France remains low, despite free vouchers increasing uptake. More information and concerted action are needed to reach national public health goals for pediatric asthma patients.

Area of Science:

  • Pediatric Pulmonology
  • Public Health
  • Immunology

Background:

  • Annual influenza vaccination is recommended for French patients with chronic respiratory diseases, including asthma, since 2000.
  • Free influenza vaccination vouchers are provided to patients with chronic respiratory diseases, extended to all asthmatic patients in 2006.
  • Vaccination coverage rates in asthmatic children have historically been below public health objectives.

Purpose of the Study:

  • To examine the influenza vaccination coverage rate in asthmatic children in France for the 2006-2007 season.
  • To identify factors influencing vaccination uptake in this pediatric population.
  • To assess the impact of free vaccination vouchers on coverage rates.

Main Methods:

  • A cross-sectional study of 433 asthmatic children aged 6-17 years who consulted a pediatric pulmonologist.
  • Data collected between March and September 2007 in eight French hospitals.
  • Vaccination coverage rates analyzed for the 2006-2007, 2005-2006, and 2004-2005 seasons, with reasons for non-vaccination recorded.

Main Results:

  • The influenza vaccination coverage rate for the 2006-2007 season was 15.7%, a slight increase from previous seasons (13.9% in 2005-2006, 10.9% in 2004-2005).
  • General practitioners administered 72.1% of the vaccinations.
  • Lack of information was the primary reason for non-vaccination (42%). Free vouchers significantly increased coverage (31% vs. 5.9%, p < 0.001).

Conclusions:

  • Influenza vaccination coverage in French asthmatic children in 2006-2007 was substantially below the national target of 75% for 2008.
  • Free vaccination vouchers demonstrated a significant positive impact on coverage rates.
  • Concerted actions are necessary to improve influenza vaccination uptake in asthmatic children.

More Related Videos

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

Related Concept Videos

Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Vaccinations01:51

Vaccinations

Overview
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma